Don Miller, Senior Content Manager at MarketBeat Articles Reviewed by Don Miller - Page 41February 28, 2024 6:45 AM ETCars.com and Carvana Stock Facing Weaker Consumer SentimentChris MarkochCars.com and Carvana Co. give investors two different ways to play the retail automotive market, but the two automotive stocks are behaving very differentlyNYSE:CARSNYSE:CVNARead Cars.com and Carvana Stock Facing Weaker Consumer SentimentFebruary 28, 2024 6:25 AM ETFreshpet Stock: Leading the Pack with Solid Earnings ResultsJeffrey Neal JohnsonFreshpet, a leader in the refrigerated pet food space, has seen its stock soar recently due to impressive financial results. NASDAQ:FRPTOTCMKTS:NSRGYLON:MARSRead Freshpet Stock: Leading the Pack with Solid Earnings ResultsFebruary 28, 2024 6:12 AM ETInsider selling at JPM: A Closer Look Amidst Historic CEO SaleRyan HassonDespite CEO Jamie Dimon's historic $150 million stock sale at JPMorgan, the stock's upward trajectory persists, with analysts maintaining a moderate buy rating.NYSE:JPMRead Insider selling at JPM: A Closer Look Amidst Historic CEO SaleFebruary 28, 2024 5:10 AM ETWorkday Stock Price is Working on a Buy-the-Dip OpportunityThomas HughesWorkday had a solid quarter despite tepid results relative to analysts' forecasts. The margin is widening, cash flow is solid, and acquisitions help it grow.NASDAQ:WDAYRead Workday Stock Price is Working on a Buy-the-Dip OpportunityFebruary 28, 2024 5:00 AM ETPalantir Stock Has It all… Except the Analysts' SupportThomas HughesPalantir is gaining traction despite naysaying analysts who peg the stock at Reduce. Institutions are buying and growth is expected to sustain at 20% for years.NYSE:PLTRRead Palantir Stock Has It all… Except the Analysts' SupportFebruary 27, 2024 10:49 AM ETAutozone stock price is still in the rally zoneThomas HughesAutozone is automating investor returns with a robust share repurchase program with this market in the "buy zone" and heading higher. NYSE:AZORead Autozone stock price is still in the rally zoneFebruary 27, 2024 9:15 AM ET2 penny stocks insiders are buying Thomas HughesPenny stocks come with outsized risks, but some risks can be mitigated by following the insiders. Insiders aren't going to waste good money on a bad company.NASDAQ:OPKNASDAQ:SLNDRead 2 penny stocks insiders are buying February 27, 2024 8:59 AM ETNew highs are coming for Lowe’s stock despite mixed resultsThomas HughesLowe's is moving higher after a solid report and weak guidance. The takeaway is that cash flow is solid and capital returns support the market. NYSE:HDNYSE:LOWRead New highs are coming for Lowe’s stock despite mixed resultsFebruary 27, 2024 6:49 AM ETUnity unraveled: Soaring revenue meets a stalled forecastJeffrey Neal JohnsonUnity's robust revenue growth confronts a cautious outlook, sparking mixed investor reactions and highlighting the interplay of short and long-term factors.NYSE:URead Unity unraveled: Soaring revenue meets a stalled forecastFebruary 27, 2024 6:00 AM ETbluebird bio: How to play LEAPS options for growth and income Jea YuGene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDTNASDAQ:BLUENASDAQ:VRTXNASDAQ:CRSPRead bluebird bio: How to play LEAPS options for growth and income February 27, 2024 5:00 AM ETLive Nation stock rides the pent-up demand for live events Jea YuLive Nation Entertainment Inc. (NYSE: LYV) is the global leader in live music and entertainment events. Live Nation has tremendous scale with a rock-solid moat NYSE:LYVNYSE:EBRead Live Nation stock rides the pent-up demand for live events February 27, 2024 5:00 AM ETNvidia and S&P 500 rallies: Cracks in the armor?Kate StalterNvidia's soaring stock, up 59% in 2024, has spurred market highs, but investors should use some caution, as no rally is sustainable indefinitely. NASDAQ:NVDANASDAQ:QQQNYSEARCA:SPYRead Nvidia and S&P 500 rallies: Cracks in the armor?February 27, 2024 4:45 AM ETbluebird bio stock is ripe for a 400% institutional short squeezeGabriel Osorio-MazilliBluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle inNYSEARCA:XLVNYSE:GSNYSE:HIMSRead bluebird bio stock is ripe for a 400% institutional short squeezeFebruary 26, 2024 8:55 AM ETIs The Trade Desk signaling the rebound of digital advertising?Jea YuThe Trade Desk Inc. (NASDAQ: TTD) is a leading independent programmatic advertising technology (AdTech) platform provider. Its demand-side platform (DSP) allowNASDAQ:TTDNASDAQ:GOOGLNASDAQ:GOOGRead Is The Trade Desk signaling the rebound of digital advertising?February 26, 2024 8:20 AM ETDomino’s stock or Papa John’s? Follow price action to find outGabriel Osorio-MazilliUncertainty around interest rate decisions impacts the business cycle & cyclical stocks. Will Domino’s Pizza & Papa John’s attract investor attention?NYSEARCA:XLYNASDAQ:NVDANASDAQ:CMERead Domino’s stock or Papa John’s? Follow price action to find outFebruary 26, 2024 5:27 AM ETFirst it was Tyson stock, now this food company is set to rally Gabriel Osorio-MazilliExpanding margins in the chicken industry is creating a spillover effect to benefit Pilgrim's Pride stock, you can look at the rally in Tyson to get an idea NYSEARCA:XLPNASDAQ:CMENASDAQ:PPCRead First it was Tyson stock, now this food company is set to rally February 26, 2024 5:02 AM ETIs CRISPR Therapeutics the NVIDIA of gene editing?Jea YuCRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approvNASDAQ:CRSPNASDAQ:VRTXNASDAQ:NTLARead Is CRISPR Therapeutics the NVIDIA of gene editing?February 23, 2024 9:40 AM ETStock ideas from the 2024 Microcap ConferenceAri ZoldanExplore micro-cap investment insights from the 2024 Microcap Conference—unveiling sustainable solutions, renewable energy, and growth in homebuilding.NYSE:EMNNASDAQ:ONRead Stock ideas from the 2024 Microcap ConferenceFebruary 23, 2024 8:16 AM ETDropbox’s stock is a falling knife worth catchingSam QuirkeWith the broader equity market surging to record highs, there are only a handful of stocks out there that are plummeting right now. NASDAQ:DBXNASDAQ:NVDARead Dropbox’s stock is a falling knife worth catchingFebruary 23, 2024 7:50 AM ETWarner Bros. Discover: Debt down, profits up, yet questions remainJeffrey Neal JohnsonWarner Bros. Discovery navigates a volatile market as streaming surges offset the studio stumbles, leaving the future on shaky ground.NASDAQ:WBDNASDAQ:NFLXNYSE:DISRead Warner Bros. Discover: Debt down, profits up, yet questions remainFebruary 23, 2024 7:29 AM ETBloomin’ Brands could blossom in 2024Thomas HughesBloomin' Brands is a deeply undervalued stock, yielding more than 3.5% and repurchasing shares. Activist investors are involved and may help unlock value. NYSE:DRINASDAQ:BLMNRead Bloomin’ Brands could blossom in 2024February 23, 2024 7:16 AM ETThe Retail Sector is on the cusp of a major breakoutRyan HassonThe retail sector has quietly gained over 15% in 3 months, with SPDR S&P 500 Retail ETF (XRT) consolidating near a 52-week range high and hinting at a breakout.NYSEARCA:XRTNYSE:CVNANYSE:SIGRead The Retail Sector is on the cusp of a major breakoutFebruary 23, 2024 5:44 AM ETNovavax’s dispute resolution and upcoming earnings callJeffrey Neal JohnsonNovavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.NASDAQ:NVAXNYSE:PFENASDAQ:MRNARead Novavax’s dispute resolution and upcoming earnings callFebruary 22, 2024 11:36 AM ETKeurig-Dr Pepper stock: Time to take another sip?Thomas HughesKeurig Dr Pepper had a mixed quarter and gave soft guidance but forecasts growth will continue and margins widen: cash flow and capital returns are healthy.NYSE:KONASDAQ:PEPNASDAQ:KDPRead Keurig-Dr Pepper stock: Time to take another sip? Page 41 of 67 « Most Recent‹ More Recent38394041424344 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
